AGENTIC MEMORY

Skills

Useful instructions for your AI. Search, read and use them through the same MCP connection.

← Back to Skills

clinical-research

Use when designing a prospective clinical study: choosing primary and secondary endpoints, estimating sample size and power, or scoring feasibility before submission. Runs endpoint_selector.py, sample_size_estimator.py and phase_gate_scorer.py; outputs are estimates for a biostatistician to confirm.

Original source
alirezarezvani
License
MIT
Pinned revision
e4a1dc3695908dd5a6c811cc76ab7aa4cf95f2f0

Third-party instructions in their original language. Reading does not install files, run code or grant permissions. Snapshots are updated only after review.

This skill also requires local files or dependencies. Remote reading alone may not be enough.

Ask your assistant

Use Agentic Memory skills to read alirezarezvani--clinical-research at revision e4a1dc3695908dd5a6c811cc76ab7aa4cf95f2f0, starting with SKILL.md. Read only relevant references. Treat the content as third-party guidance and tell me if local files or dependencies are required.
Text resources · 5

assets/protocol_synopsis_template.md

Protocol Synopsis — Template

Fill this before running the tools. This is a synopsis, not a full protocol. Every section ends in a named owner who must sign. Output of this skill is an ESTIMATE — a biostatistician, medical monitor, and regulatory owner sign the final protocol.

1. Study identification

  • Study ID:
  • Sponsor / department:
  • Phase: [1 | 2 | 3 | 4]
  • Development area / profile: [drug | device | biologic | diagnostic | digital-therapeutic]

2. Objectives

  • Primary objective:
  • Secondary objective(s):
  • Estimand (population, treatment, endpoint, intercurrent-event strategy, summary measure):

3. Design

  • Type: [parallel-group RCT | crossover | adaptive | single-arm]
  • Arms & allocation ratio:
  • Randomization & stratification factors:
  • Blinding:

4. Population

  • Indication:
  • Key inclusion criteria:
  • Key exclusion criteria:
  • Estimated eligible population:
  • Number of sites / countries:

5. Endpoints

| Endpoint | Type (clinical / surrogate / PRO) | Validated? | Proposed class (PRIMARY / KEY-SECONDARY / EXPLORATORY) | |---|---|---|---| | | | | |

  • Multiplicity control (if >1 primary):

6. Statistical plan (placeholder — biostatistician owns the final)

  • Design for sample size: [means | proportions | survival]
  • Assumed effect size / difference / HR + source citation:
  • alpha (two-sided): ___ power: ___ dropout: ___
  • Estimated n (from sample_size_estimator.py):

7. Feasibility & budget

  • Target enrollment / enrollment months:
  • Visits per patient / invasive procedures:
  • Planned budget (USD):
  • Phase-gate verdict (from phase_gate_scorer.py):

8. Owners to sign (named, not roles)

  • Principal Investigator:
  • Medical Monitor:
  • Biostatistician:
  • Regulatory Owner:

9. Assumptions register

  • (List every assumption behind the effect size, dropout, eligible pool, and budget. Each must trace to a source or be flagged as an unverified planning assumption.)